Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors
ChemMedChem · 2026
DOI: 10.1002/cmdc.70489 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Matteo Lusardi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Università degli Studi di Genova, Genova, Italy. Hauptthemen laut MEDLINE: Sirtuin 2, Sirtuin 1, Thiourea, Drug Design. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Genova, Ministero dell'Università e della Ricerca, Ministero della Salute.
Abstract (Originalsprache)
A series of pyrazolyl‐thioureas was designed and synthesized as novel sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) inhibitors. Compounds were prepared through a multistep, divergent procedure starting from amino pyrazole intermediates. Biological evaluation revealed that several derivatives exhibited significant SIRT2 inhibitory activity, with compounds 6a and 7f emerging as the most promising inhibitors, showing IC 50 values of 2.2 and 13.6 µM, respectively. Selected compounds displayed selective antiproliferative activity against HepG2 hepatocellular carcinoma cells, while showing limited cytotoxicity toward normal fibroblasts. The biological properties of 6a and 7f were further investigated by analyzing SIRT1 activity and correlating antiproliferative activity with tubulin acetylation. Docking simulations identified the molecular basis of SIRT1 and SIRT2 inhibition. Overall, these results identify pyrazolyl thioureas as a promising scaffold for novel SIRT1 and SIRT2 inhibitors with potential anticancer applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Università degli Studi di Genova, Genova, Italy.
- Department of Experimental Medicine, Università degli Studi di Genova, Genova, Italy.
- AOM - IRCCS Ospedale Policlinico San Martino, Genova, Italy.
ORCID-Profile: Matteo Lusardi, Deianira Bellitto, Matteo Raineri, Giorgia Guccione, Chiara Brullo, Marco Ponassi, Santina Bruzzone, Andrea Spallarossa
Förderung
- Università degli Studi di Genova
- Ministero dell'Università e della Ricerca
- Ministero della Salute
- University of Genoa
- Ministry for Universities and Research
- Italian Ministry of Health
Zitieren
APA
Lusardi, M., Astigiano, C., Bellitto, D., Raineri, M., Guccione, G., Salis, A., Cichero, E., Brullo, C., Ponassi, M., Bruzzone, S., & Spallarossa, A. (2026). Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.70489
Vancouver
Lusardi M, Astigiano C, Bellitto D, Raineri M, Guccione G, Salis A, et al. Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors. ChemMedChem. 2026. doi:10.1002/cmdc.70489
BibTeX
@article{Lusardi2026,
author = {Lusardi, Matteo and Astigiano, Cecilia and Bellitto, Deianira and Raineri, Matteo and Guccione, Giorgia and Salis, Annalisa and Cichero, Elena and Brullo, Chiara and Ponassi, Marco and Bruzzone, Santina and Spallarossa, Andrea},
title = {Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70489}
}
EUVIMED